Human P2X7 Full Length Protein (VLP)

Customer Reviews
Cat. No. / Size
Price
Availability
Qty
P27-H52P3-20ug
$620.00
In Stock - Delivery in 2-3 weeks
P27-H52P3-100ug
$1235.00
In Stock - Delivery in 2-3 weeks
P27-H52P3-500ug (250ug X 2)
$4305.00
In Stock - Delivery in 2-3 weeks

Product Details

  • Application

    1. Immunization
    2. Cell based assay (FACS or functional assay)
    3. Screening (ELISA)
  • Synonyms

    P2X7

  • Source

    Human P2X7 Full Length Protein (VLP) (P27-H52P3) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Tyr 595 (Accession # Q99572-1).

    Predicted N-terminus: Met

  • Molecular Characterization

    *The isotype control of empty/mock VLP (Cat. No. VLP-N5213) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

    2. Synthesis Process

      Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Formulation

    The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

    Supplied as 0.2 μm filtered solution in PBS, 0.2 M Arginine, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping and Storage

    This product is supplied and shipped on dry ice.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     P2X7 ELISA

    Immobilized Human P2X7 Full Length Protein (VLP) (Cat. No. P27-H52P3) at 5 μg/mL (100 μL/well) can bind Monoclonal Anti-P2X7 Antibody, Mouse IgG2b with a linear range of 0.002-0.156 μg/mL (QC tested).

    Protocol
  • Identity-DLS

     P2X7 DLS

    The mean peak Radius of VLP is 60-80 nm with more than 95% intensity as determined by dynamic light scattering (DLS).

Customer Reviews
Writing Reviews

Background

P2X7 is a ligand-gated ion channel driven by high concentrations of extracellular ATP under pathological conditions. Extensively expressed on immune and microglial cells, it acts as a critical upstream switch to activate the NLRP3 inflammasome, making it a premier therapeutic target for neuroinflammation, depression, and chronic inflammatory disorders.

Recent Advances

 
Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background